APO Research
Talk to an analyst

APO RESEARCH · REPORT

Liver Fibrosis Drug

Liver fibrosis is the scarring process that represents the liver’s response to injury. In the same way as skin and other organs heal wounds through deposition of collagen and other matrix constituents so the liver repairs injury through the deposition of new collagen.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Liver fibrosis is the scarring process that represents the liver’s response to injury. In the same way as skin and other organs heal wounds through deposition of collagen and other matrix constituents so the liver repairs injury through the deposition of new collagen.

Selected research

Industry Growth & Trends

Global Liver Fibrosis Drug Industry Growth and Trends Forecast to 2032

21 December 202593 pages

Choose your research edition.

Industry ResearchLiver Fibrosis Drug Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Liver Fibrosis Drug Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Liver Fibrosis Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Liver Fibrosis Drug Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Liver Fibrosis Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Liver fibrosis is the scarring process that represents the liver’s response to injury. In the same way as skin and other organs heal wounds through deposition of collagen and other matrix constituents so the liver repairs injury through the deposition of new collagen.

Global Liver Fibrosis Drug key players include Gilead, Biogen Idec, Merck KGaA, Bristol-Myers Squibb Company, Roche, etc. Global top five manufacturers hold a share over 60%.

North America is the largest market, with a share about 50%, followed by Europe and Japan, both have a share about 30 percent.

Read the full market overview

In terms of product, Nucleoside is the largest segment, with a share over 45%. And in terms of application, the largest application is Hepatitis, followed by Liver Fibrosis.

Report Scope

This report provides a structured, data-driven view of the global Liver Fibrosis Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Liver Fibrosis Drug market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Liver Fibrosis Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant toLiver Fibrosis Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Liver Fibrosis Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Liver Fibrosis Drug Market by Company

Gilead

Biogen Idec

Merck KGaA

Bristol-Myers Squibb Company

Roche

Merck & Co.

Tri-Prime

Liver Fibrosis Drug Segment by Type

Nucleoside

Interferon

Other

Liver Fibrosis Drug Segment by Application

Hepatitis

Liver Fibrosis

Other

Liver Fibrosis Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liver Fibrosis Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Liver Fibrosis Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liver Fibrosis Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Liver Fibrosis Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Liver Fibrosis Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Nucleoside Table 2. Major Company of Interferon Table 3. Major Company of Other Table 4. Global Liver Fibrosis Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Liver Fibrosis Drug Sales by Type (2021-2026) & (k units) Table 6. Global Liver Fibrosis Drug Sales Market Share in Volume by Type (2021-2026) Table 7. Global Liver Fibrosis Drug Sales by Type (2021-2026) & (US$ Million) Table 8. Global Liver Fibrosis Drug Sales Market Share in Value by Type (2021-2026) Table 9. Global Liver Fibrosis Drug Price by Type (2021-2026) & (USD/unit) Table 10. Global Liver Fibrosis Drug Sales by Type (2027-2032) & (k units) Table 11. Global Liver Fibrosis Drug Sales Market Share in Volume by Type (2027-2032) Table 12. Global Liver Fibrosis Drug Sales by Type (2027-2032) & (US$ Million) Table 13. Global Liver Fibrosis Drug Sales Market Share in Value by Type (2027-2032) Table 14. Global Liver Fibrosis Drug Price by Type (2027-2032) & (USD/unit) Table 15. North America Liver Fibrosis Drug Sales by Type (2021-2026) & (k units) Table 16. North America Liver Fibrosis Drug Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Liver Fibrosis Drug Sales by Type (2021-2026) & (k units) Table 18. Europe Liver Fibrosis Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Liver Fibrosis Drug Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Liver Fibrosis Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Liver Fibrosis Drug Sales by Type (2021-2026) & (k units) Table 22. Latin America Liver Fibrosis Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Liver Fibrosis Drug Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Liver Fibrosis Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Liver Fibrosis Drug Industry Trends Table 26. Liver Fibrosis Drug Industry Drivers Table 27. Liver Fibrosis Drug Industry Opportunities and Challenges Table 28. Liver Fibrosis Drug Industry Restraints Table 29. Global Liver Fibrosis Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Liver Fibrosis Drug Revenue Market Share by Company (2021-2026) Table 31. Global Liver Fibrosis Drug Sales by Company (2021-2026) & (k units) Table 32. Global Liver Fibrosis Drug Sales Share by Company (2021-2026) Table 33. Global Liver Fibrosis Drug Market Price by Company (2021-2026) & (USD/unit) Table 34. Global Liver Fibrosis Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Liver Fibrosis Drug Major Company Production Sites and Headquarters Table 36. Global Liver Fibrosis Drug Company, Product Type & Application Table 37. Global Liver Fibrosis Drug Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Liver Fibrosis Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Liver Fibrosis Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Liver Fibrosis Drug Sales by Region (2021-2026) & (k units) Table 42. Global Liver Fibrosis Drug Sales Market Share in Volume by Region (2021-2026) Table 43. Global Liver Fibrosis Drug Sales by Region (2021-2026) & (US$ Million) Table 44. Global Liver Fibrosis Drug Sales Market Share in Value by Region (2021-2026) Table 45. Global Liver Fibrosis Drug Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. Global Liver Fibrosis Drug Sales by Region (2027-2032) & (k units) Table 47. Global Liver Fibrosis Drug Sales Market Share in Volume by Region (2027-2032) Table 48. Global Liver Fibrosis Drug Sales by Region (2027-2032) & (US$ Million) Table 49. Global Liver Fibrosis Drug Sales Market Share in Value by Region (2027-2032) Table 50. Global Liver Fibrosis Drug Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 51. Global Liver Fibrosis Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Liver Fibrosis Drug Sales by Application (2021-2026) & (k units) Table 53. Global Liver Fibrosis Drug Sales Market Share in Volume by Application (2021-2026) Table 54. Global Liver Fibrosis Drug Sales by Application (2021-2026) & (US$ Million) Table 55. Global Liver Fibrosis Drug Sales Market Share in Value by Application (2021-2026) Table 56. Global Liver Fibrosis Drug Price by Application (2021-2026) & (USD/unit) Table 57. Global Liver Fibrosis Drug Sales by Application (2027-2032) & (k units) Table 58. Global Liver Fibrosis Drug Sales Market Share in Volume by Application (2027-2032) Table 59. Global Liver Fibrosis Drug Sales by Application (2027-2032) & (US$ Million) Table 60. Global Liver Fibrosis Drug Sales Market Share in Value by Application (2027-2032) Table 61. Global Liver Fibrosis Drug Price by Application (2027-2032) & (USD/unit) Table 62. North America Liver Fibrosis Drug Sales by Application (2021-2026) & (k units) Table 63. North America Liver Fibrosis Drug Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Liver Fibrosis Drug Sales by Application (2021-2026) & (k units) Table 65. Europe Liver Fibrosis Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Liver Fibrosis Drug Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Liver Fibrosis Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Liver Fibrosis Drug Sales by Application (2021-2026) & (k units) Table 69. Latin America Liver Fibrosis Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Liver Fibrosis Drug Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Liver Fibrosis Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Gilead Company Information Table 73. Gilead Business Overview Table 74. Gilead Liver Fibrosis Drug Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 75. Gilead Liver Fibrosis Drug Product Portfolio Table 76. Gilead Recent Development Table 77. Biogen Idec Company Information Table 78. Biogen Idec Business Overview Table 79. Biogen Idec Liver Fibrosis Drug Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 80. Biogen Idec Liver Fibrosis Drug Product Portfolio Table 81. Biogen Idec Recent Development Table 82. Merck KGaA Company Information Table 83. Merck KGaA Business Overview Table 84. Merck KGaA Liver Fibrosis Drug Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 85. Merck KGaA Liver Fibrosis Drug Product Portfolio Table 86. Merck KGaA Recent Development Table 87. Bristol-Myers Squibb Company Company Information Table 88. Bristol-Myers Squibb Company Business Overview Table 89. Bristol-Myers Squibb Company Liver Fibrosis Drug Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Bristol-Myers Squibb Company Liver Fibrosis Drug Product Portfolio Table 91. Bristol-Myers Squibb Company Recent Development Table 92. Roche Company Information Table 93. Roche Business Overview Table 94. Roche Liver Fibrosis Drug Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Roche Liver Fibrosis Drug Product Portfolio Table 96. Roche Recent Development Table 97. Merck & Co. Company Information Table 98. Merck & Co. Business Overview Table 99. Merck & Co. Liver Fibrosis Drug Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Merck & Co. Liver Fibrosis Drug Product Portfolio Table 101. Merck & Co. Recent Development Table 102. Tri-Prime Company Information Table 103. Tri-Prime Business Overview Table 104. Tri-Prime Liver Fibrosis Drug Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Tri-Prime Liver Fibrosis Drug Product Portfolio Table 106. Tri-Prime Recent Development Table 107. North America Liver Fibrosis Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 108. North America Liver Fibrosis Drug Sales by Country (2021-2026) & (k units) Table 109. North America Liver Fibrosis Drug Sales Market Share by Country (2021-2026) Table 110. North America Liver Fibrosis Drug Sales Forecast by Country (2027-2032) & (k units) Table 111. North America Liver Fibrosis Drug Sales Market Share Forecast by Country (2027-2032) Table 112. North America Liver Fibrosis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 113. North America Liver Fibrosis Drug Market Size by Country (2021-2026) & (US$ Million) Table 114. North America Liver Fibrosis Drug Market Share by Country (2021-2026) Table 115. North America Liver Fibrosis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 116. North America Liver Fibrosis Drug Market Share Forecast by Country (2027-2032) Table 117. Europe Liver Fibrosis Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 118. Europe Liver Fibrosis Drug Sales by Country (2021-2026) & (k units) Table 119. Europe Liver Fibrosis Drug Sales Market Share by Country (2021-2026) Table 120. Europe Liver Fibrosis Drug Sales Forecast by Country (2027-2032) & (k units) Table 121. Europe Liver Fibrosis Drug Sales Market Share Forecast by Country (2027-2032) Table 122. Europe Liver Fibrosis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. Europe Liver Fibrosis Drug Market Size by Country (2021-2026) & (US$ Million) Table 124. Europe Liver Fibrosis Drug Market Share by Country (2021-2026) Table 125. Europe Liver Fibrosis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. Europe Liver Fibrosis Drug Market Share Forecast by Country (2027-2032) Table 127. Asia-Pacific Liver Fibrosis Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 128. Asia-Pacific Liver Fibrosis Drug Sales by Country (2021-2026) & (k units) Table 129. Asia-Pacific Liver Fibrosis Drug Sales Market Share by Country (2021-2026) Table 130. Asia-Pacific Liver Fibrosis Drug Sales Forecast by Country (2027-2032) & (k units) Table 131. Asia-Pacific Liver Fibrosis Drug Sales Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Liver Fibrosis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Liver Fibrosis Drug Market Size by Country (2021-2026) & (US$ Million) Table 134. Asia-Pacific Liver Fibrosis Drug Market Share by Country (2021-2026) Table 135. Asia-Pacific Liver Fibrosis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Asia-Pacific Liver Fibrosis Drug Market Share Forecast by Country (2027-2032) Table 137. Latin America Liver Fibrosis Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 138. Latin America Liver Fibrosis Drug Sales by Country (2021-2026) & (k units) Table 139. Latin America Liver Fibrosis Drug Sales Market Share by Country (2021-2026) Table 140. Latin America Liver Fibrosis Drug Sales Forecast by Country (2027-2032) & (k units) Table 141. Latin America Liver Fibrosis Drug Sales Market Share Forecast by Country (2027-2032) Table 142. Latin America Liver Fibrosis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Latin America Liver Fibrosis Drug Market Size by Country (2021-2026) & (US$ Million) Table 144. Latin America Liver Fibrosis Drug Market Share by Country (2021-2026) Table 145. Latin America Liver Fibrosis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Latin America Liver Fibrosis Drug Market Share Forecast by Country (2027-2032) Table 147. Middle East and Africa Liver Fibrosis Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 148. Middle East and Africa Liver Fibrosis Drug Sales by Country (2021-2026) & (k units) Table 149. Middle East and Africa Liver Fibrosis Drug Sales Market Share by Country (2021-2026) Table 150. Middle East and Africa Liver Fibrosis Drug Sales Forecast by Country (2027-2032) & (k units) Table 151. Middle East and Africa Liver Fibrosis Drug Sales Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Liver Fibrosis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Liver Fibrosis Drug Market Size by Country (2021-2026) & (US$ Million) Table 154. Middle East and Africa Liver Fibrosis Drug Market Share by Country (2021-2026) Table 155. Middle East and Africa Liver Fibrosis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Middle East and Africa Liver Fibrosis Drug Market Share Forecast by Country (2027-2032) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Liver Fibrosis Drug Distributors List Table 160. Liver Fibrosis Drug Customers List Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. Liver Fibrosis Drug Image Figure 2. Global Liver Fibrosis Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Liver Fibrosis Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Liver Fibrosis Drug Sales (2021-2032) & (k units) Figure 5. Nucleoside Image Figure 6. Global Nucleoside Sales YoY Growth (2021-2032) & (k units) Figure 7. Interferon Image Figure 8. Global Interferon Sales YoY Growth (2021-2032) & (k units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Liver Fibrosis Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Liver Fibrosis Drug Market Share by Type 2025 VS 2032 Figure 13. North America Liver Fibrosis Drug Sales Market Share in Volume by Type in 2025 Figure 14. North America Liver Fibrosis Drug Sales Market Share in Value by Type in 2025 Figure 15. Europe Liver Fibrosis Drug Sales Market Share in Volume by Type in 2025 Figure 16. Europe Liver Fibrosis Drug Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Liver Fibrosis Drug Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Liver Fibrosis Drug Sales Market Share in Value by Type in 2025 Figure 19. Latin America Liver Fibrosis Drug Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Liver Fibrosis Drug Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Liver Fibrosis Drug Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Liver Fibrosis Drug Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Liver Fibrosis Drug Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hepatitis Image Figure 26. Global Hepatitis Sales YoY Growth (2021-2032) & (k units) Figure 27. Liver Fibrosis Image Figure 28. Global Liver Fibrosis Sales YoY Growth (2021-2032) & (k units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Liver Fibrosis Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Liver Fibrosis Drug Market Share by Application 2025 VS 2032 Figure 33. North America Liver Fibrosis Drug Sales Market Share in Volume by Application in 2025 Figure 34. North America Liver Fibrosis Drug Sales Market Share in Value by Application in 2025 Figure 35. Europe Liver Fibrosis Drug Sales Market Share in Volume by Application in 2025 Figure 36. Europe Liver Fibrosis Drug Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Liver Fibrosis Drug Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Liver Fibrosis Drug Sales Market Share in Value by Application in 2025 Figure 39. Latin America Liver Fibrosis Drug Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Liver Fibrosis Drug Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Liver Fibrosis Drug Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Liver Fibrosis Drug Sales Market Share in Value by Application in 2025 Figure 43. North America Liver Fibrosis Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Liver Fibrosis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Liver Fibrosis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Liver Fibrosis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Liver Fibrosis Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Liver Fibrosis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Liver Fibrosis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Liver Fibrosis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Liver Fibrosis Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Liver Fibrosis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Liver Fibrosis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Liver Fibrosis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Liver Fibrosis Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Liver Fibrosis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Liver Fibrosis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Liver Fibrosis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Liver Fibrosis Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Liver Fibrosis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Liver Fibrosis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Liver Fibrosis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Liver Fibrosis Drug Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Liver Fibrosis Drug Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Nucleoside
  • Interferon
  • Other
Applications
  • Hepatitis
  • Liver Fibrosis
  • Other
Companies covered
  • Gilead
  • Biogen Idec
  • Merck KGaA
  • Bristol-Myers Squibb Company
  • Roche
  • Merck & Co.
  • Tri-Prime

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Liver Fibrosis Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Liver Fibrosis Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Liver Fibrosis Drug Market by Type
  6. 1.3.1 Nucleoside
  7. 1.3.2 Interferon
  8. 1.3.3 Other
  9. 1.4 Global Liver Fibrosis Drug Market Size by Type
  10. 1.4.1 Global Liver Fibrosis Drug Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Liver Fibrosis Drug Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Liver Fibrosis Drug Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Liver Fibrosis Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Liver Fibrosis Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Liver Fibrosis Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Liver Fibrosis Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Liver Fibrosis Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Liver Fibrosis Drug Industry Trends
  2. 2.2 Liver Fibrosis Drug Industry Drivers
  3. 2.3 Liver Fibrosis Drug Industry Opportunities and Challenges
  4. 2.4 Liver Fibrosis Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Liver Fibrosis Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Liver Fibrosis Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Liver Fibrosis Drug Price (2021-2026)
  4. 3.4 Global Liver Fibrosis Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Liver Fibrosis Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Liver Fibrosis Drug Company, Product Type & Application
  7. 3.7 Global Liver Fibrosis Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Liver Fibrosis Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Liver Fibrosis Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Liver Fibrosis Drug Tier 1, Tier 2, and Tier 3
4 Liver Fibrosis Drug Regional Status and Outlook
  1. 4.1 Global Liver Fibrosis Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Liver Fibrosis Drug Historic Market Size by Region
  3. 4.2.1 Global Liver Fibrosis Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Liver Fibrosis Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Liver Fibrosis Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Liver Fibrosis Drug Forecasted Market Size by Region
  7. 4.3.1 Global Liver Fibrosis Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Liver Fibrosis Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Liver Fibrosis Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Liver Fibrosis Drug by Application
  1. 5.1 Liver Fibrosis Drug Market by Application
  2. 5.1.1 Hepatitis
  3. 5.1.2 Liver Fibrosis
  4. 5.1.3 Other
  5. 5.2 Global Liver Fibrosis Drug Market Size by Application
  6. 5.2.1 Global Liver Fibrosis Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Liver Fibrosis Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Liver Fibrosis Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Liver Fibrosis Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Liver Fibrosis Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Liver Fibrosis Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Liver Fibrosis Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Liver Fibrosis Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Gilead
  2. 6.1.1 Gilead Company Information
  3. 6.1.2 Gilead Business Overview
  4. 6.1.3 Gilead Liver Fibrosis Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Gilead Liver Fibrosis Drug Product Portfolio
  6. 6.1.5 Gilead Recent Developments
  7. 6.2 Biogen Idec
  8. 6.2.1 Biogen Idec Company Information
  9. 6.2.2 Biogen Idec Business Overview
  10. 6.2.3 Biogen Idec Liver Fibrosis Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Biogen Idec Liver Fibrosis Drug Product Portfolio
  12. 6.2.5 Biogen Idec Recent Developments
  13. 6.3 Merck KGaA
  14. 6.3.1 Merck KGaA Company Information
  15. 6.3.2 Merck KGaA Business Overview
  16. 6.3.3 Merck KGaA Liver Fibrosis Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck KGaA Liver Fibrosis Drug Product Portfolio
  18. 6.3.5 Merck KGaA Recent Developments
  19. 6.4 Bristol-Myers Squibb Company
  20. 6.4.1 Bristol-Myers Squibb Company Company Information
  21. 6.4.2 Bristol-Myers Squibb Company Business Overview
  22. 6.4.3 Bristol-Myers Squibb Company Liver Fibrosis Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bristol-Myers Squibb Company Liver Fibrosis Drug Product Portfolio
  24. 6.4.5 Bristol-Myers Squibb Company Recent Developments
  25. 6.5 Roche
  26. 6.5.1 Roche Company Information
  27. 6.5.2 Roche Business Overview
  28. 6.5.3 Roche Liver Fibrosis Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Roche Liver Fibrosis Drug Product Portfolio
  30. 6.5.5 Roche Recent Developments
  31. 6.6 Merck & Co.
  32. 6.6.1 Merck & Co. Company Information
  33. 6.6.2 Merck & Co. Business Overview
  34. 6.6.3 Merck & Co. Liver Fibrosis Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Merck & Co. Liver Fibrosis Drug Product Portfolio
  36. 6.6.5 Merck & Co. Recent Developments
  37. 6.7 Tri-Prime
  38. 6.7.1 Tri-Prime Company Information
  39. 6.7.2 Tri-Prime Business Overview
  40. 6.7.3 Tri-Prime Liver Fibrosis Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Tri-Prime Liver Fibrosis Drug Product Portfolio
  42. 6.7.5 Tri-Prime Recent Developments
7 North America by Country
  1. 7.1 North America Liver Fibrosis Drug Sales by Country
  2. 7.1.1 North America Liver Fibrosis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Liver Fibrosis Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Liver Fibrosis Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Liver Fibrosis Drug Market Size by Country
  6. 7.2.1 North America Liver Fibrosis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Liver Fibrosis Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Liver Fibrosis Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Liver Fibrosis Drug Sales by Country
  2. 8.1.1 Europe Liver Fibrosis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Liver Fibrosis Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Liver Fibrosis Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Liver Fibrosis Drug Market Size by Country
  6. 8.2.1 Europe Liver Fibrosis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Liver Fibrosis Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Liver Fibrosis Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Liver Fibrosis Drug Sales by Country
  2. 9.1.1 Asia-Pacific Liver Fibrosis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Liver Fibrosis Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Liver Fibrosis Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Liver Fibrosis Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Liver Fibrosis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Liver Fibrosis Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Liver Fibrosis Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Liver Fibrosis Drug Sales by Country
  2. 10.1.1 South America Liver Fibrosis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Liver Fibrosis Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Liver Fibrosis Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Liver Fibrosis Drug Market Size by Country
  6. 10.2.1 South America Liver Fibrosis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Liver Fibrosis Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Liver Fibrosis Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Liver Fibrosis Drug Sales by Country
  2. 11.1.1 Middle East and Africa Liver Fibrosis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Liver Fibrosis Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Liver Fibrosis Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Liver Fibrosis Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Liver Fibrosis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Liver Fibrosis Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Liver Fibrosis Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Liver Fibrosis Drug Value Chain Analysis
  2. 12.1.1 Liver Fibrosis Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Liver Fibrosis Drug Production Mode & Process
  7. 12.2 Liver Fibrosis Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Liver Fibrosis Drug Distributors
  10. 12.2.3 Liver Fibrosis Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst